Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.
about
Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in CancerDeconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patientsTumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.In silico models of cancerThe tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancerAssessment of predictive markers for placental inflammatory response in preterm births.Trial Watch: Peptide-based anticancer vaccines.Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.Reciprocal complementation of the tumoricidal effects of radiation and natural killer cellsPeripheral blood cells inform on the presence of breast cancer: a population-based case-control studyTLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.Protein signaling networks from single cell fluctuations and information theory profiling.Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.The Delta Neutrophil Index as a predictive marker of histological chorioamnionitis in patients with preterm premature rupture of membranes: A retrospective studySingle low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice.Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.Immunotherapy for liver tumors: present status and future prospects.Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.Toll-like receptor signalling on Tregs: to suppress or not to suppress?Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity.Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.Vaccine-based clinical trials in ovarian cancer.T regulatory cells in B-cell malignancy - tumour support or kiss of death?Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.Immunotherapeutic approaches to treat multiple myelomaStroma as an Active Player in the Development of the Tumor Microenvironment.Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
P2860
Q26767257-786C48D8-3092-4202-9A7D-B02D4A93BED2Q33800793-D8286771-8C2E-40FE-B016-DCDC6E4AE9D2Q34097414-E9AFF6C9-E6B5-4000-8CC2-E8C86F6DEB5FQ34137584-945734CC-325D-4104-9755-2859D6F2DD20Q34208784-E5540641-3E9D-48C5-B71B-66C653A360ADQ34267746-3FB22BF7-C0AD-4219-B910-7080275504DBQ34301303-F1483776-DE95-4095-95EA-80DD5AD4AF7DQ34483345-5AA3511C-C14E-4AF0-A77F-A714BBA95861Q34542781-A7B7F8AA-157E-4F9A-804E-CFEE1CFAEEAAQ34698158-98176F22-D9DA-4401-B3FC-F49D398558F6Q34782137-3B39B9CD-CB16-43EA-99E4-DD5D5EC391B0Q34880391-FEF6B975-A3F7-4073-BCAD-5E89F2F48728Q34898280-3697AC97-00A6-47BE-8FE0-C6007D6DC49DQ34978109-BC703647-7F52-4A30-9644-C93127124F84Q35214729-9F3505DA-926B-49D7-AABB-65124C73EBB5Q36302261-B1D6DA41-4C30-4DF4-AF6A-BFD2652F0316Q36388495-6F1280EF-4BFC-4505-9DFE-7B7E09C0DBC6Q36981396-A5F90E14-1CF0-4F6A-9F68-D806928683A1Q37028767-15FAC7BC-D69E-4B4F-95BD-502AF82327DDQ37032635-95060983-22FE-4E49-92FC-EBE5CF7ADE75Q37144014-822BBEEC-1412-4DB6-BAD4-0DAAFC0986C8Q37174945-0342A2C8-592D-426A-BF25-7A64EB9B5AEDQ37186819-FD9D841D-F9AE-4B1F-8E81-8621C87AD572Q37362880-6828A3C0-F507-4FC9-B445-FCF99823DECAQ37486166-ED6B5443-1041-4F91-904B-602039AFCDAAQ37577925-7D8F4097-B03B-42C5-8E87-458CEBFC3523Q37706248-8F76E438-A188-4BDD-B692-3130589C7BC1Q37728654-692E9D75-A0FE-4BF7-87D3-196E9273EBF7Q37822746-641AA04B-2E51-4449-A331-426177385AB8Q37892583-593C7275-B792-49E1-91CC-50105B4D8270Q37960166-17F5B938-E07A-4DDB-979F-8EF11C35D8A0Q37974301-7943A312-E8E5-4B54-9DE1-1328FE199C0FQ38057233-B1B84089-F6E3-4AB3-A2A6-C61D380B868FQ38170498-33B93DC6-8814-4C68-BEAC-025698F6491AQ38171067-BCBE935D-20E9-4497-B346-58F41085034AQ38238231-4D33A887-5713-43DE-AF2D-7FA4878141C8Q38435415-BB05DCBD-1A50-4F96-AD9C-194FE85F84B3Q38491431-07F72A63-1DDB-407D-B4DE-702036309CBAQ38819757-41B5BF5E-BFC6-46A3-95B7-F54F329EED25Q38823310-01A23A0C-50ED-4EBD-AE1F-070BAFF3F6FA
P2860
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dynamic cross-talk between tum ...... at the tumor microenvironment.
@en
type
label
Dynamic cross-talk between tum ...... at the tumor microenvironment.
@en
prefLabel
Dynamic cross-talk between tum ...... at the tumor microenvironment.
@en
P2093
P2860
P1476
Dynamic cross-talk between tum ...... at the tumor microenvironment.
@en
P2093
Diego O Croci
Gabriel A Rabinovich
María J Rico
O Graciela Scharovsky
Pablo Matar
P2860
P2888
P304
P356
10.1007/S00262-007-0343-Y
P577
2007-06-15T00:00:00Z